Sigyn Therapeutics, Inc. – ‘S-1/A’ on 4/10/24 – ‘EX-101.CAL’

On:  Wednesday, 4/10/24, at 5:28pm ET   ·   Accession #:  1493152-24-14251   ·   File #:  333-265782

in

this entire Filing. an “Entity” Search.

Show

Documents searched

and

each “hit”. the 1st “hit”.

↓↑Hints

Pre-Effective Amendment to Registration Statement (General Form)   —   Form S-1   —   SA’33

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: S-1/A       Pre-Effective Amendment to Registration Statement   HTML   4.66M 
                (General Form)                                                   
 2: EX-10.25    Material Contract                                   HTML     24K 
 3: EX-10.26    Material Contract                                   HTML     20K 
 4: EX-23.1     Consent of Expert or Counsel                        HTML     19K 
15: R1          Cover                                               HTML     54K 
16: R2          Consolidated Balance Sheets                         HTML    119K 
17: R3          Consolidated Balance Sheets (Parenthetical)         HTML     42K 
18: R4          Consolidated Statements of Operations               HTML    100K 
19: R5          Consolidated Statements of Changes in               HTML     94K 
                Shareholders' Equity                                             
20: R6          Consolidated Statements of Cash Flows               HTML    124K 
21: R7          Organization and Principal Activities               HTML     46K 
22: R8          Basis of Presentation                               HTML     36K 
23: R9          Summary of Significant Accounting Policies          HTML    135K 
24: R10         Property and Equipment                              HTML     42K 
25: R11         Intangible Assets                                   HTML     38K 
26: R12         Convertible Promissory Debentures                   HTML   1.15M 
27: R13         Stockholders? Deficit                               HTML     64K 
28: R14         Operating Leases                                    HTML     81K 
29: R15         Related Party Transactions                          HTML     53K 
30: R16         Income Taxes                                        HTML     64K 
31: R17         Earnings Per Share                                  HTML     60K 
32: R18         Commitments and Contingencies                       HTML     34K 
33: R19         Subsequent Events                                   HTML     50K 
34: R20         Advance From Shareholder                            HTML     24K 
35: R21         Summary of Significant Accounting Policies          HTML    182K 
                (Policies)                                                       
36: R22         Property and Equipment (Tables)                     HTML     37K 
37: R23         Intangible Assets (Tables)                          HTML     36K 
38: R24         Convertible Promissory Debentures (Tables)          HTML    744K 
39: R25         Operating Leases (Tables)                           HTML     68K 
40: R26         Income Taxes (Tables)                               HTML     57K 
41: R27         Earnings Per Share (Tables)                         HTML     56K 
42: R28         Organization and Principal Activities (Details      HTML     47K 
                Narrative)                                                       
43: R29         Basis of Presentation (Details Narrative)           HTML     40K 
44: R30         Summary of Significant Accounting Policies          HTML     36K 
                (Details Narrative)                                              
45: R31         Schedule of Property and Equipment (Details)        HTML     35K 
46: R32         Property and Equipment (Details Narrative)          HTML     21K 
47: R33         Schedule of Intangible Assets (Details)             HTML     28K 
48: R34         Schedule of Estimated Amortization Expenses         HTML     24K 
                Related to Intangible Assets (Details)                           
49: R35         Intangible Assets (Details Narrative)               HTML     22K 
50: R36         Schedule of Convertible Notes Payable (Details)     HTML    110K 
51: R37         Schedule of Convertible Notes Payable (Details)     HTML    176K 
                (Parenthetical)                                                  
52: R38         Schedule of Principal Payments Due on Convertible   HTML     28K 
                Promissory Debentures (Details)                                  
53: R39         Schedule of Changes in Convertible Notes (Details)  HTML    104K 
54: R40         Schedule of Changes in Note Discounts (Details)     HTML    129K 
55: R41         Convertible Promissory Debentures (Details          HTML    618K 
                Narrative)                                                       
56: R42         Stockholders? Deficit (Details Narrative)           HTML     88K 
57: R43         Schedule of Operating Lease Cost and Supplemental   HTML     35K 
                Cash Flow Information (Details)                                  
58: R44         Schedule of Maturities of Operating Lease           HTML     45K 
                Liabilities (Details)                                            
59: R45         Operating Leases (Details Narrative)                HTML     33K 
60: R46         Related Party Transactions (Details Narrative)      HTML     63K 
61: R47         Schedule of Reconciliation of Statutory Income Tax  HTML     32K 
                Rates and Effective Tax Rate (Details)                           
62: R48         Schedule of Deferred Tax Assets (Details)           HTML     32K 
63: R49         Income Taxes (Details Narrative)                    HTML     23K 
64: R50         Schedule of Anti Dilutive Securities (Details)      HTML     30K 
65: R51         Schedule of Computation of Basic and Diluted Net    HTML     52K 
                Income Per Share (Details)                                       
66: R52         Commitments and Contingencies (Details Narrative)   HTML     34K 
67: R53         Subsequent Events (Details Narrative)               HTML    103K 
68: R54         Advance From Shareholder (Details Narrative)        HTML     25K 
11: XML         IDEA XML File -- Filing Summary                      XML    120K 
14: XML         XBRL Instance -- forms-1a_htm                        XML   4.34M 
10: EXCEL       IDEA Workbook of Financial Report Info              XLSX    214K 
 6: EX-101.CAL  XBRL Calculations -- sign-20231231_cal               XML    151K 
 7: EX-101.DEF  XBRL Definitions -- sign-20231231_def                XML    543K 
 8: EX-101.LAB  XBRL Labels -- sign-20231231_lab                     XML    945K 
 9: EX-101.PRE  XBRL Presentations -- sign-20231231_pre              XML    779K 
 5: EX-101.SCH  XBRL Schema -- sign-20231231                         XSD    140K 
12: JSON        XBRL Instance as JSON Data -- MetaLinks              369±   541K 
13: ZIP         XBRL Zipped Folder -- 0001493152-24-014251-xbrl      Zip    570K 

‘EX-101.CAL’   —   XBRL Calculations — sign-20231231_cal

This Exhibit is an XBRL File.

6 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 5/10/23  Sigyn Therapeutics, Inc.          S-1/A                 64:8.6M                                   M2 Compliance LLC/FA
 2/28/23  Sigyn Therapeutics, Inc.          S-1/A                 26:7.5M                                   M2 Compliance LLC/FA
 6/23/22  Sigyn Therapeutics, Inc.          S-1                   63:7.7M                                   M2 Compliance LLC/FA
 3/09/22  Sigyn Therapeutics, Inc.          8-K:1,5,9   3/09/22   11:1M                                     M2 Compliance LLC/FA
 8/31/20  Sigyn Therapeutics, Inc.          8-K:1,8,9   8/25/20    5:1.5M                                   Genesis Filings LLC/FA
 5/27/15  Sigyn Therapeutics, Inc.          S-1                   10:3.4M                                   S2 Filings LLC/FA